DR Horton Company Top Insiders

DHI Stock  USD 145.88  0.14  0.1%   
Under 90 percent of DR Horton's insiders are activelly selling. The analysis of insiders' sentiment of trading DR Horton stock suggests that a large number of insiders are panicking at this time. DR Horton employs about 13.4 K people. The company is managed by 16 executives with a total tenure of roughly 144 years, averaging almost 9.0 years of service per executive, having 840.63 employees per reported executive.
David Auld  CEO
President, Chief Executive Officer
Donald Horton  Chairman
Executive Chairman of the Board

DR Horton's Insider Buying Vs Selling

10

 
Selling
 
Buying

Latest Trades

2024-03-20David V AuldDisposed 25000 @ 156.33View
2024-03-14Barbara K AllenDisposed 449 @ 149.39View
2024-01-30Barbara K AllenDisposed 1748 @ 143.26View
2023-12-14Bradley S AndersonDisposed 10000 @ 152View
2023-12-11Josh GottheimerAcquired @ 138.9
2023-11-28Barbara K AllenDisposed 470 @ 126.21View
2023-08-07Michael R BuchananDisposed 1639 @ 127.03View
2023-06-20Bill W WheatDisposed 32000 @ 117.81View
2023-05-17Paul J RomanowskiDisposed 40000 @ 112.16View
2023-05-03Michael J MurrayDisposed 54000 @ 110.21View
Monitoring DR Horton's insider sentiment can offer insights into its future performance, as insiders often have access to more information about their company's operations, financial health, and upcoming initiatives than the general public. However, it's essential to note that insider trading is regulated by securities laws, and insiders are required to disclose their trades publicly to ensure transparency and prevent unfair advantages based on non-public information.

Acquired vs Disposed

Filed vs Not Filed

Insider sentiment refers to the collective sentiment or feeling of DR Horton's insiders - typically its officers, directors, and beneficial owners holding more than a certain percentage of the company's stock - about the future prospects of DR Horton. This sentiment is often gauged based on the trading activities of these insiders. If insiders are purchasing more shares of their own company, it may be interpreted as a bullish sentiment, indicating that they believe DR Horton's stock will rise in value. Conversely, if insiders are selling shares, it might be seen as bearish, suggesting they expect the stock price to drop.
  
Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in DR Horton. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in rate.
For more detail on how to invest in DHI Stock please use our How to Invest in DR Horton guide.

DR Horton's Workforce Through the Years

Please note that employee historical analysis has become an increasingly important factor for investors assessing the risk associated with DR Horton's future performance. Based on our forecasts, it is anticipated that DHI will maintain a workforce of under 13450 employees by May 2024.
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid

DR Horton's latest congressional trading

Congressional trading in companies like DR Horton, is subject to rigorous scrutiny to prevent conflicts of interest and insider trading. This is governed by multiple SEC regulations which were established to foster transparency and deter members of Congress from leveraging non-public information for personal gain. This oversight helps maintain public trust and ensures that investments in DR Horton by those in governmental positions are based on the same information available to the general public.
2024-03-14Representative Josh GottheimerAcquired Under $15KVerify
2022-10-05Senator Tommy TubervilleAcquired Under $15KVerify
2020-08-05Senator Ron WydenAcquired Under $15KVerify

DR Horton Management Team Effectiveness

The company has Return on Asset of 0.1216 % which means that on every $100 spent on assets, it made $0.1216 of profit. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of 0.2166 %, implying that it generated $0.2166 on every 100 dollars invested. DR Horton's management efficiency ratios could be used to measure how well DR Horton manages its routine affairs as well as how well it operates its assets and liabilities. As of now, DR Horton's Return On Capital Employed is increasing as compared to previous years. The DR Horton's current Return On Equity is estimated to increase to 0.37, while Return On Tangible Assets are projected to decrease to 0.05. As of now, DR Horton's Other Current Assets are increasing as compared to previous years. The DR Horton's current Total Current Assets is estimated to increase to about 34.8 B, while Intangible Assets are projected to decrease to under 9.5 M.
The DR Horton's current Net Income Applicable To Common Shares is estimated to increase to about 5.7 B, while Common Stock Shares Outstanding is projected to decrease to under 320.7 M.

DR Horton Workforce Comparison

DR Horton is one of the top stocks in number of employees category among related companies. The total workforce of Consumer Discretionary industry is currently estimated at about 60,641. DR Horton totals roughly 13,450 in number of employees claiming about 22% of stocks in Consumer Discretionary industry.

DR Horton Profit Margins

The company has Net Profit Margin of 0.13 %, which implies that it may need a different competitive strategy as even a very small decline in it revenue may erase profits and result in a net loss. This is way below average. In the same way, it shows Net Operating Margin of 0.16 %, which entails that for every 100 dollars of revenue, it generated $0.16 of operating income.
Current ValueLast YearChange From Last Year 10 Year Trend
Gross Profit Margin0.150.1942
Significantly Down
Pretty Stable
Net Profit Margin0.04230.0467
Moderately Down
Very volatile
Operating Profit Margin0.06330.087
Way Down
Slightly volatile
Pretax Profit Margin0.06050.0725
Fairly Down
Slightly volatile
Return On Assets0.05060.0972
Way Down
Slightly volatile
Return On Equity0.370.3515
Sufficiently Up
Slightly volatile

DR Horton Insider Trading History

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific DR Horton insiders, such as employees or executives, is commonly permitted as long as it does not rely on DR Horton's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases, DR Horton insiders must file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
 
Dot-com Bubble
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
Buy/Sell Ratio# Purchases Trades# Sales TradesTotal Shares PurchasedTotal Shares Sold
2024-03-01
0.7193
41
57
 89,795 
 145,592 
2023-12-01
0.6
21
35
 853,467 
 1,436,021 
2023-09-01
1.0
1
1
 1,129,924 
 1,639 
2023-06-01
1.3333
16
12
 292,193 
 326,809 
2023-03-01
0.6081
45
74
 2,416,266 
 3,098,354 
2022-12-01
0.5
17
34
 734,238 
 1,011,783 
2022-06-01
1.5
3
2
 91,762 
 19,896 
2022-03-01
0.8281
53
64
 288,953 
 198,779 
2021-12-01
0.434
23
53
 1,105,716 
 1,539,283 
2021-09-01
0.2
1
5
 60,000 
 4,535,582 
2021-06-01
0.6364
7
11
 4,697,766 
 528,192 
2021-03-01
0.7377
45
61
 821,427 
 1,156,302 
2020-12-01
0.4048
17
42
 653,367 
 25,136,378 
2020-09-01
0.3333
3
9
 66,000 
 211,034 
2020-06-01
0.5714
4
7
 4,000 
 8,833 
2020-03-01
0.7857
44
56
 332,813 
 332,874 
2019-12-01
0.5294
18
34
 763,227 
 1,292,051 
2019-09-01
0.4
2
5
 12,500 
 32,000 
2019-03-01
0.6852
37
54
 298,150 
 318,704 
2018-12-01
0.8696
20
23
 1,027,382 
 1,128,481 
2018-09-01
0.5
1
2
 3,000 
 6,000 
2018-03-01
0.7451
38
51
 647,627 
 750,556 
2017-12-01
0.5417
13
24
 638,542 
 913,278 
2017-09-01
0.4444
4
9
 24,666 
 50,272 
2017-03-01
0.8158
31
38
 412,592 
 2,310,854 
2016-12-01
1.0
9
9
 425,648 
 504,630 
2016-09-01
0.6364
7
11
 27,333 
 59,666 
2016-06-01
0.5714
4
7
 223,000 
 414,979 
2016-03-01
1.1667
21
18
 351,312 
 95,415 
2015-12-01
0.6364
7
11
 353,129 
 468,961 
2015-09-01
0.4444
4
9
 77,000 
 3,012,500 
2015-03-01
2.25
18
8
 408,721 
 88,221 
2014-12-01
0.5625
9
16
 382,359 
 833,508 
2014-06-01
0.7143
5
7
 279,100 
 519,447 
2014-03-01
1.0
16
16
 482,332 
 306,261 
2013-12-01
0.3333
4
12
 498,280 
 1,117,471 
2013-06-01
0.75
6
8
 98,499 
 189,498 
2013-03-01
3.0
15
5
 441,333 
 42,750 
2012-12-01
0.5
2
4
 325,000 
 446,875 
2012-09-01
0.6471
11
17
 484,667 
 959,782 
2012-06-01
0.375
3
8
 216,000 
 482,982 
2012-03-01
0.5
10
20
 364,000 
 869,254 
2011-12-01
2.0
2
1
 275,625 
 176,475 
2010-12-01
1.0
2
2
 437,500 
 330,182 
2010-09-01
1.0
4
4
 209,990 
 14,680 
2010-03-01
0.5
2
4
 66,600 
 121,070 
2009-12-01
0.5
2
4
 333,000 
 567,672 
2008-06-01
0.5
6
12
 45,559 
 61,099 
2008-03-01
0.4865
18
37
 1,285,324 
 596,574 
2007-09-01
1.0
1
1
 1,816 
 1,816 
2007-06-01
0.625
5
8
 286,828 
 300,948 
2007-03-01
0.6667
2
3
 24,735 
 35,858 
2006-09-01
1.3333
4
3
 22,480 
 22,380 
2006-06-01
2.8
14
5
 602,933 
 128,725 
2006-03-01
0.5
3
6
 15,503 
 31,006 
2005-12-01
0.75
3
4
 14,117 
 14,542 
2005-09-01
1.0
3
3
 21,559 
 21,559 
2005-06-01
0.3235
11
34
 216,794 
 456,790 
2005-03-01
1.0
1
1
 55,566 
 55,566 
2004-12-01
0.6
3
5
 13,016 
 17,037 
2004-09-01
2.0
2
1
 61,318 
 60,568 
2004-06-01
4.5
9
2
 309,297 
 5,835 
2004-03-01
4.0
4
1
 32,336 
 4,313 
2003-12-01
0.1961
10
51
 153,410 
 173,569 
2003-09-01
0.0597
4
67
 60,000 
 834,450 

DR Horton Notable Stakeholders

A DR Horton stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as DR Horton often face trade-offs trying to please all of them. DR Horton's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting DR Horton's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
David AuldPresident, Chief Executive OfficerProfile
Donald HortonExecutive Chairman of the BoardProfile
Michael MurrayCo-Chief Operating Officer, Executive Vice PresidentProfile
Bill WheatChief Financial Officer, Executive Vice PresidentProfile
Paul RomanowskiCo-Chief Operating Officer, Executive Vice PresidentProfile
Matt FarrisPresident RegionProfile
Michael BuchananIndependent DirectorProfile
Michael HewattIndependent DirectorProfile
Barbara AllenIndependent DirectorProfile
Bradley AndersonIndependent DirectorProfile
Thomas MontanoCorporate VPProfile
Jessica HansenVP of CommunicationsProfile
Maribess MillerIndependent DirectorProfile
Aron OdomPrincipal Accounting OfficerProfile
Benjamin CarsonIndependent DirectorProfile
Collin DawsonVice TreasurerProfile

About DR Horton Management Performance

The success or failure of an entity such as DR Horton often depends on how effective the management is. DR Horton management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of DHI management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the DHI management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Last ReportedProjected for Next Year
Return On Tangible Assets 0.1  0.05 
Return On Capital Employed 0.52  0.55 
Return On Assets 0.1  0.05 
Return On Equity 0.35  0.37 
The data published in DR Horton's official financial statements usually reflect DR Horton's business processes, product offerings, services, and other fundamental events. But there are other numbers, ratios, or fundamental indicators derived from these statements that are easier to understand and visualize within the underlying realities that drive quantitative information of DR Horton. For example, before you start analyzing numbers published by DHI accountants, it's critical to develop an understanding of what DR Horton's liquidity, profitability, and earnings quality are in the context of the Household Durables space in which it operates.
Please note, the presentation of DR Horton's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, DR Horton's management is honest, while the outside auditors are strict and uncompromising. Whatever the case, the imprecision that can be found in DR Horton's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of DR Horton. Please utilize our Beneish M Score to check the likelihood of DR Horton's management manipulating its earnings.

DR Horton Workforce Analysis

Traditionally, organizations such as DR Horton use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare DR Horton within its industry.

DR Horton Manpower Efficiency

Return on DR Horton Manpower

Revenue Per Employee2.6M
Revenue Per Executive2.2B
Net Income Per Employee356.5K
Net Income Per Executive299.7M
Working Capital Per Employee1.8M
Working Capital Per Executive1.5B
When determining whether DR Horton offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of DR Horton's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Dr Horton Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Dr Horton Stock:
Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in DR Horton. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in rate.
For more detail on how to invest in DHI Stock please use our How to Invest in DR Horton guide.
Note that the DR Horton information on this page should be used as a complementary analysis to other DR Horton's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Watchlist Optimization module to optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm.

Complementary Tools for DHI Stock analysis

When running DR Horton's price analysis, check to measure DR Horton's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy DR Horton is operating at the current time. Most of DR Horton's value examination focuses on studying past and present price action to predict the probability of DR Horton's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move DR Horton's price. Additionally, you may evaluate how the addition of DR Horton to your portfolios can decrease your overall portfolio volatility.
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Is DR Horton's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of DR Horton. If investors know DHI will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about DR Horton listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
0.022
Dividend Share
1.05
Earnings Share
13.87
Revenue Per Share
106.305
Quarterly Revenue Growth
0.065
The market value of DR Horton is measured differently than its book value, which is the value of DHI that is recorded on the company's balance sheet. Investors also form their own opinion of DR Horton's value that differs from its market value or its book value, called intrinsic value, which is DR Horton's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because DR Horton's market value can be influenced by many factors that don't directly affect DR Horton's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between DR Horton's value and its price as these two are different measures arrived at by different means. Investors typically determine if DR Horton is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, DR Horton's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.